95296 ⎘
Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group containing two hetero rings
Sub-classes:INHIBITORS OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES 1 AND 4
#2Methods for modifying RNA splicing
#3PHARMACOPHORES, COMPOUNDS AND METHODS HAVING APPLICATION IN THE TREATMENT OF CANCER THROUGH INHIBITION OF CYP17A1 AND CYP19A1
#4Pharmacophores, compounds and methods having application in the treatment of cancer through inhibition of CYP17A1 and CYP19A1
#5Substituted N-[2-(4-phenoxypiperidin-1-yl)-2-(1,3-thiazol-5-yl)ethyl]benzamide and N-[2-(4-benzyloxypiperidin-1-yl)-2-(1,3-thiazol-5-yl)ethyl]benzamide derivatives P2X7 receptor antagonists
#6Heteroaromatic compounds as BTK inhibitors
#7Orexin receptor antagonists
#8Heteroaromatic compounds as BTK inhibitors
#9HETEROAROMATIC COMPOUNDS AS BTK INHIBITORS
#10Dichroic dye compound, polarizing film, and uses thereof
#11Orexin receptor antagonists
#12NOL3 is a predictor of patient outcome
#13NOL3 is a predictor of patient outcome
#14Arylosulfonamides for the treatment of CNS diseases
#15Morpholino substituted bicyclic pyrimidine urea or carbamate derivatives as mTOR inhibitors
#16PROCESS FOR THE PREPARATION OF AN HIV INTEGRASE INHIBITOR
#17Arylosulfonamides for the treatment of CNS diseases
#18Synthesis of epothilones, intermediates thereto and analogues thereof
#19Actinic-ray- or radiation-sensitive resin composition, compound and method of forming pattern using the composition
#20Phenol derivative
#21ACTINIC-RAY- OR RADIATION-SENSITIVE RESIN COMPOSITION, COMPOUND AND METHOD OF FORMING PATTERN USING THE COMPOSITION
#22Synthesis of epothilones, intermediates thereto and analogues thereof
#23NOL3 is a predictor of patient outcome
#24Sphingosine Kinase Inhibitors and Methods of Their Use
#25Pyrazine-2-carboxyamide derivatives
#26Coloring composition, thermal transfer recording ink sheet, thermal transfer recording method, color toner, inkjet ink, color filter, and dye compound
#27Thiazolylidine urea and amide derivatives and methods of use thereof
#28Mucarinic Agonists and Methods of Use Thereof
#29Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC-chemokine receptor ligands
#30Quinolonecarboxylic acid compounds, preparation methods and pharmaceutical uses thereof
#31Modulators of ATP-binding cassette transporters
#32Synthesis of epothilones, intermediates thereto and analogues thereof
#33SPHINGOSINE KINASE INHIBITORS AND METHODS OF THEIR USE
#34Therapeutic benimidazole compounds
#35Compounds to treat alzheimer's disease
#36Pyrazine-2-carboxyamide derivatives
#37[B]-fused bicyclic proline derivatives and their use for treating arthritic conditions